Vainzof, Mariz 
; Rusticci, Monica S; Marie, Suely Kazue Nagahashi; Zatz, Mayana ; Tsanaclis, Ana Maria Crous; Silva, Helga Cristina Almeida da
Source: Neurology. Conference titles: American Academy of Neurology Annual Meeting. Unidades: FM, IB
Assunto: NEUROLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAINZOF, Mariz et al. Screening for mutation in the "alfa" 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in patients with malignant-hyperthemia and central core myopathy. Neurology. Canada: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 1999APA
Vainzof, M., Rusticci, M. S., Marie, S. K. N., Zatz, M., Tsanaclis, A. M. C., & Silva, H. C. A. da. (1999). Screening for mutation in the "alfa" 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in patients with malignant-hyperthemia and central core myopathy. Neurology. Canada: Faculdade de Medicina, Universidade de São Paulo.NLM
Vainzof M, Rusticci MS, Marie SKN, Zatz M, Tsanaclis AMC, Silva HCA da. Screening for mutation in the "alfa" 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in patients with malignant-hyperthemia and central core myopathy. Neurology. 1999 ; 52( 06): A331.[citado 2024 nov. 08 ]Vancouver
Vainzof M, Rusticci MS, Marie SKN, Zatz M, Tsanaclis AMC, Silva HCA da. Screening for mutation in the "alfa" 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in patients with malignant-hyperthemia and central core myopathy. Neurology. 1999 ; 52( 06): A331.[citado 2024 nov. 08 ]
